Connection

William Hrushesky to Treatment Outcome

This is a "connection" page, showing publications William Hrushesky has written about Treatment Outcome.
Connection Strength

0.234
  1. Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ. 2016 Dec 30; 355:i6286.
    View in: PubMed
    Score: 0.059
  2. Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. Breast Cancer Res Treat. 2009 Nov; 118(2):345-59.
    View in: PubMed
    Score: 0.036
  3. Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther. 2003 Jun; 2(2):105-11.
    View in: PubMed
    Score: 0.023
  4. Androgen suppression and irradiation for locally advanced prostate cancer. Lancet. 2002 Dec 14; 360(9349):1987; author reply 1987-8.
    View in: PubMed
    Score: 0.022
  5. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
    View in: PubMed
    Score: 0.019
  6. Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar; 175(3):245-61.
    View in: PubMed
    Score: 0.016
  7. Erythropoietin usage in patients with cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):243-6.
    View in: PubMed
    Score: 0.014
  8. Breast cancer and the menstrual cycle. J Surg Oncol. 1993 May; 53(1):1-3.
    View in: PubMed
    Score: 0.012
  9. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer. 2010 Nov 30; 10:656.
    View in: PubMed
    Score: 0.010
  10. Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007 Nov 01; 110(9):1880-8.
    View in: PubMed
    Score: 0.008
  11. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):852-7.
    View in: PubMed
    Score: 0.008
  12. Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005. Breast Cancer Res Treat. 2006 Jun; 97(3):341-3.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.